Bad news in the HIV world today. The decision to apply excise tax to medical cannabis affects Canadians living in pain, including people living with HIV. This decision is inappropriate and is an unfair burden on patients who suffer from chronic pain said Gary Lacasse. CAS is in alignment with the Arthritis Society‘s position to strongly urge the Federal Government to reconsider the proposed excise duty framework for cannabis products through its review of Bill C-74, and the impact it will have on the lives of those who rely on medical cannabis as medicine. To know more about this decision, read this press release from Arthritis Society:
Patient And Health Groups Call Out “Unfair” Federal Plan To Tax Medical Cannabis